Calcium Sulfate
ApprovedSmall molecule
Calcium Sulfate is one of 6 small molecule programs targeting Tibia Fracture. It is currently in Approved.
1
Indications
1
Total Trials
0
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Tibia Fracture
#DrugCompanyPhaseTrials
1Advil
KKenvue Brands
Phase 3
Inductos
PfizerApproved
Genotropin
EMD SeronoPhase 2
Calcium Sulfate
UUniversity of Washington
Approved
Deltavit
HHyundai Pharmaceutical Co., LTD.
Phase 1
Tylenol
KKenvue Brands
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Calcium Sulfate. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- UUniversity of Washington